How Much Does Teriparatide Cost?
The cost of teriparatide varies significantly depending on factors such as the specific product, dosage, quantity, and insurance coverage. For instance, a 30-day supply of Forteo, a brand-name teriparatide injection, can cost over $1,500 without insurance. Generic versions may offer lower prices, but out-of-pocket expenses can still be substantial [1].
What Influences Teriparatide Pricing?
Pricing for teriparatide is influenced by several factors. These include the manufacturing costs, research and development investments, market demand, and the pricing strategies of pharmaceutical companies. The availability of generic alternatives also plays a role in market pricing [1].
Are There Cheaper Alternatives to Teriparatide?
While teriparatide is a primary treatment for osteoporosis, other medications are available. These include bisphosphonates like alendronate (Fosamax) and risedronate (Actonel), as well as denosumab (Prolia) and romosozumab (Evenity). The cost-effectiveness of these alternatives compared to teriparatide can vary, and patient suitability differs [2].
When Does Teriparatide Patent Exclusivity End?
The patent protection for teriparatide and its associated brand-name formulations has expired or is nearing expiration in many regions, paving the way for generic competition. For example, key patents for Forteo have expired, allowing for the introduction of generic teriparatide [3]. Information on specific patent expiry dates for various teriparatide products can be found on DrugPatentWatch.com [3].
Who Manufactures Teriparatide and Its Generics?
Multiple pharmaceutical companies manufacture teriparatide. While Eli Lilly and Company originally developed and marketed Forteo, the advent of patent expirations has led to other manufacturers producing generic versions of teriparatide. These include companies such as Teva Pharmaceuticals and other generic drug makers [3].
What Are the Potential Side Effects of Teriparatide?
Common side effects associated with teriparatide treatment include nausea, joint pain, headache, and leg cramps. More serious, though rare, side effects can include a significant drop in blood pressure upon standing and a potential increased risk of osteosarcoma, particularly in animal studies [4].
How is Teriparatide Administered?
Teriparatide is administered as a subcutaneous injection, typically once daily. It is usually prescribed for a limited duration, often around 18 to 24 months, due to concerns about long-term safety, particularly the potential risk of bone cancer observed in animal studies [4].
What Medical Conditions Does Teriparatide Treat?
Teriparatide is primarily used to treat osteoporosis in postmenopausal women and in men at high risk for fracture. It is also used for the treatment of osteoporosis associated with prolonged therapy with glucocorticoids [4].
How Does Teriparatide Work?
Teriparatide is a form of parathyroid hormone (PTH). It works by stimulating bone formation, increasing bone mineral density, and reducing the risk of vertebral and non-vertebral fractures. It is administered in a pulsatile fashion to promote bone building [4].
What Clinical Data Supports Teriparatide's Efficacy?
Clinical trials have demonstrated that teriparatide significantly reduces the risk of fractures. Studies have shown its effectiveness in increasing bone mineral density in the lumbar spine and hip, and in reducing the incidence of new vertebral and clinical fractures [4].
What Are Patient Concerns Regarding Teriparatide?
Patients often express concerns about the cost of teriparatide, the requirement for daily injections, and potential side effects. The limited duration of treatment and the need for continued therapy with other agents after completing teriparatide treatment are also common considerations [4].
How Does Teriparatide Compare to Other Osteoporosis Treatments?
Compared to bisphosphonates, teriparatide is a bone-forming agent, while bisphosphonates are bone-resorbing inhibitors. Teriparatide is generally considered more potent in increasing bone mineral density and reducing fracture risk, especially in severe osteoporosis cases. However, bisphosphonates are often a first-line treatment due to their cost and ease of administration [2, 4].
---
Sources:
1. https://www.goodrx.com/forteo
2. https://www.drugpatentwatch.com/blog/drug-pricing-and-patents-explained/
3. https://www.drugpatentwatch.com/search/teriparatide/
4. https://www.mayoclinic.org/drugs-supplements/teriparatide-subcutaneous-injection-route/side-effects/drh-20067178